These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 38228080

  • 1. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study.
    Lee J, Lim SH, Chung JH, Song W, Sung HH, Jeong BC, Park SH.
    Cancer Res Treat; 2024 Jul; 56(3):871-876. PubMed ID: 38228080
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [Abstract] [Full Text] [Related]

  • 3. Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.
    Birtle AJ, Jones R, Chester J, Lewis R, Biscombe K, Johnson M, Blacker A, Bryan RT, Catto JWF, Choudhury A, Das P, Jagdev S, Powles T, Wagstaff J, Cheung KC, Cafferty F, Hall E.
    J Clin Oncol; 2024 May 01; 42(13):1466-1471. PubMed ID: 38350047
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
    Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT, Harris C, Winterbottom A, Blacker A, Catto JWF, Chakraborti P, Donovan JL, Elliott PA, French A, Jagdev S, Jenkins B, Keeley FX, Kockelbergh R, Powles T, Wagstaff J, Wilson C, Todd R, Lewis R, Hall E.
    Lancet; 2020 Apr 18; 395(10232):1268-1277. PubMed ID: 32145825
    [Abstract] [Full Text] [Related]

  • 5. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Eur Urol Focus; 2018 Dec 18; 4(6):946-953. PubMed ID: 28753881
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS, Gupta M, Schwen ZR, Patel HD, Kates M, Johnson MH, Hahn NM, McConkey D, Bivalacqua TJ, Pierorazio PM.
    J Urol; 2018 Jul 18; 200(1):68-73. PubMed ID: 29307680
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
    Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W.
    J Urol; 2004 Oct 18; 172(4 Pt 1):1271-5. PubMed ID: 15371822
    [Abstract] [Full Text] [Related]

  • 8. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
    Kobayashi H, Obata K.
    Cancer Chemother Pharmacol; 1994 Oct 18; 35 Suppl():S14-7. PubMed ID: 7994781
    [Abstract] [Full Text] [Related]

  • 9. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA, Pallauf M, Watts EK, Lombardo KA, Campbell JA, Rezaee ME, Rouprêt M, Boorjian SA, Potretzke AM, Roshandel MR, Ploussard G, Djaladat H, Ghoreifi A, Mari A, Campi R, Khene ZE, Raman JD, Kikuchi E, Rink M, Abdollah F, Boormans JL, Fujita K, D'Andrea D, Soria F, Breda A, Hoffman-Censits J, McConkey DJ, Shariat SF, Pradere B, Singla N.
    Eur Urol Oncol; 2024 Oct 18; 7(5):1061-1068. PubMed ID: 38262800
    [Abstract] [Full Text] [Related]

  • 10. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
    Shirotake S, Kikuchi E, Tanaka N, Matsumoto K, Miyazaki Y, Kobayashi H, Ide H, Obata J, Hoshino K, Kaneko G, Hagiwara M, Kosaka T, Kanao K, Kodaira K, Hara S, Oyama M, Momma T, Miyajima A, Nakagawa K, Hasegawa S, Nakajima Y, Oya M.
    J Urol; 2015 Apr 18; 193(4):1122-8. PubMed ID: 25444957
    [Abstract] [Full Text] [Related]

  • 11. Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study.
    Song W, Jeong JY, Jeon HG, Seo SI, Jeon SS, Choi HY, Lee HM, Sung HH.
    Int J Surg; 2019 Jun 18; 66():12-17. PubMed ID: 31018160
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.
    Song YS, Cho JS, Cho KS, Doo SH, Chung BH, Kim SJ, Yang WJ, Song KH, Kim CI, Hong SJ.
    Urol Int; 2010 Jun 18; 85(1):47-51. PubMed ID: 20234122
    [Abstract] [Full Text] [Related]

  • 13. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
    Cho KS, Joung JY, Seo HK, Cho IC, Chung HS, Chung J, Lee KH.
    Cancer Chemother Pharmacol; 2011 Apr 18; 67(4):769-74. PubMed ID: 20532510
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma.
    Hung SC, Wang SS, Yang CK, Li JR, Cheng CL, Ou YC, Ho HC, Chiu KY, Chen CS.
    Anticancer Res; 2017 Apr 18; 37(4):1875-1883. PubMed ID: 28373455
    [Abstract] [Full Text] [Related]

  • 15. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
    Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF.
    J Endourol; 2017 Sep 18; 31(9):946-953. PubMed ID: 28731777
    [Abstract] [Full Text] [Related]

  • 16. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J, Collaborators.
    J Urol; 2020 Apr 18; 203(4):690-698. PubMed ID: 31702432
    [Abstract] [Full Text] [Related]

  • 17. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
    Aziz A, Dobruch J, Hendricksen K, Kluth LA, Necchi A, Noon A, Rink M, Roghmann F, Seiler R, Gontero P, Kassouf W, Shariat SF, Xylinas E, Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.
    World J Urol; 2017 Sep 18; 35(9):1401-1407. PubMed ID: 28074261
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
    Zaghloul MS, Christodouleas JP, Smith A, Abdallah A, William H, Khaled HM, Hwang WT, Baumann BC.
    JAMA Surg; 2018 Jan 17; 153(1):e174591. PubMed ID: 29188298
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience.
    Kim HS, Lee JS, Jeong CW, Kwak C, Kim HH, Ku JH.
    Int Braz J Urol; 2015 Jan 17; 41(6):1067-79. PubMed ID: 26742963
    [Abstract] [Full Text] [Related]

  • 20. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Kitamura H, Igarashi M, Tanaka T, Shindo T, Masumori N, Tamakawa M, Kawaai Y, Tsukamoto T.
    Jpn J Clin Oncol; 2012 Dec 17; 42(12):1192-6. PubMed ID: 23077244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.